Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

NCT00003296 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

Brown University